HON-N -6.11 MEQ-T 5.74 CSU-T 15.34 ARE-T 0.04 DRVN-Q 0.04 TOU-T -0.06 IAK-N -3.4771
Daily Stock Opinions and Ratings
Stockchase Opinions

James Telfser Curaleaf Holdings Inc CURA-T HOLD Oct 14, 2025

Sector as a whole has really improved, and no one's really paying attention. All balance sheets have been cleaned up with better management in place. Lots of room to get more attention, and the space will be volatile. Still a commodity-type play. Undervalued. He'd hold on.

James TelfserJames Telfser
Unknown
Unlock Rating
$4.530

Stock price when the opinion was issued

agriculture
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

Curaleaf Holdings Inc(CURA-T)

Jul 01, 2022
MJ-N down this week He has been long in cannabis. It's been a tough week. Most of this ETF is invested in Canadian stocks. Canopy this week just announced it would issue more shares, which will highly dilute shares. Canopy has been eroding capital quickly. A lot of consolidation needs to happen. The top 3-4 Canadian players are losing market share. Look to U.S. names, instead, where valuations are interesting. Names like Curaleaf are trading at low May 2020 valuations.
Founder & CIOTimothy Seymour
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
Unspecified

Curaleaf Holdings Inc(CURA-T)

Jul 04, 2022
Cannabis stocks sold off in the U.S. with many companies burning through cash. Curaleaf should continue to be a leader with cash on the balance sheet and generating cash. It is still building its business. There are challenges in the Cannabis market in the U.S. at the moment. Waiting for more legalization legislation.
President & Portfolio Man…Bruce Campbell (2)
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
BUY

Curaleaf Holdings Inc(CURA-T)

Oct 11, 2022
Allan Tong’s Discover Picks Despite inflation, Curaleaf’s Q2 was rosy with revenue growing 8% to $338 million and adjusted EBITDA rising 2.2% to 25.6% following -1.5% in Q1. Also, management lowered 2022 guidance by cutting capital spending by $25 million to $125 million. Caveats: There’s a lot of competition in any of these territories, so establishing a presence in all corners of the U.S. is crucial. Also, the path to legalization will be unpredictable, given the vagaries of American politics. You can buy Curaleaf now, but be patient. The ride up could take time, but it could soar into hyperspace any moment, too. Curaleaf boasts 10 buys and one hold at an average price target of $12.14, nearly 50% higher. Buy. Read 3 Cannabis Stocks to go Higher for our full analysis.
by Allan TongStockchase Discover
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
DON'T BUY

Curaleaf Holdings Inc(CURA-T)

Nov 09, 2022
Getting more liberalization of cannabis laws state by state in US. Good for multi-state operators like this one. Well positioned. Elephant in room is federal tax laws, but tax relief won't be for a while.
Chief Investment OfficerBrian Madden
No
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
DON'T BUY

Curaleaf Holdings Inc(CURA-T)

Oct 05, 2023

He deals with 3- to 5-year money, holds it a long time, and rides the growth of the underlying business. Canadian marijuana space is at risk. US landscape is more fertile, better capitalized, better opportunities, and more upside, especially when the US legislation becomes law.

Vice President and Partne…Darren Sissons
No
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
TRADE

Curaleaf Holdings Inc(CURA-T)

Apr 11, 2024

US rescheduling hasn't happened. Off peak. Fits and starts when there's news. Entrenched opposition. US firms can't deduct expenses like a "legitimate" business, so can't turn a profit. Trader's dream, but not for long term.

Chief Investment OfficerBrian Madden
No
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
RISKY

Curaleaf Holdings Inc(CURA-T)

Jul 22, 2024

Large issue with the company is legalizing the products(marijuana). Another worry is the over supply of products in the market. Federal laws against marijuana in USA make it hard to deal with expenses that are not deductible (100% tax rate). Could be a good investment if US legislation changes. In the meantime, would not recommend investing. 

Chief Investment OfficerBrian Madden
No
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
SELL

Curaleaf Holdings Inc(CURA-T)

Jul 09, 2025

He has no exposure in the sector. In a holding pattern. Needs the catalysts of legalization and updated banking practices for tax write offs. But who knows how long this might take. Move on.

President & Portfolio Man…Bruce Campbell (2)
No
Unlock Rating
N/A

Stock price when the opinion was issued

agriculture
premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

Curaleaf Holdings Inc(CURA-T)

Oct 01, 2025

And now for something completely risky. Though listed on the TSX, this is an American company that produces weed in that country and across Europe. As everyone knows, U.S. states have been legalizing ganja for several years and there's always speculation of whether this president or that will legalize weed for the entire country. At the end of September, Trump posted that CDB has health benefits an CURA shores skyrocketed over 30%, though they lost roughly half that the next day.

Stockchase PremiumThe Monthly Gems by Allan Tong
Unknown
Unlock Rating
$4.100

Stock price when the opinion was issued

agriculture

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

IFC-T -3.65$266
ALC-N -0.09$73.99
ABT-N -3.82$129.45
RCI.B-… 0.14$51.76
T-T -0.06$21.19

Today's Top Picks

HON-N -6.11$202.5
MEQ-T 5.74$186.49
CSU-T 15.34$3970.35
ARE-T 0.04$24.78
DRVN-Q 0.04$16.33

Popular Articles

Latest Sell Signals

BYND-Q -0.111$0.6701
MRK-N -0.59$84.11
INTC-Q 1.52$37.15
MRNA-Q 1.47$27.72
BRK.B-… 0.42$496.39

Most Recent Experts

Chris Blumas

Chris Blumas

at Raymond James Investment Counsel Ltd.

Stockchase Insights

Stockchase Insights

5i Research

James Telfser

James Telfser

Ewing Morris & Co. Investment Partners

Hap (Robert) Sneddon FCSI

Hap (Robert) Sneddon FCSI

Castlemoore Inc.

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica